FDA 483 - Topiderm Inc. - March 07, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Topiderm Inc. in Amityville, NY, was cited for significant deficiencies during an FDA inspection, primarily concerning manufacturing equipment and quality control procedures. The firm failed to qualify manufacturing equipment used for drug products distributed in the US market. Additionally, the quality control unit did not adhere to multiple written procedures, including those for customer complaint handling, change control, laboratory logbook documentation, and good documentation practices, with instances of overwritten data.
- Office
- New York District Office
- Person
ID · 6dfe2b49-0d6d-4068-919a-4e90ae57e61c